Glenview Trust CO Danaher Corp Transaction History

Glenview Trust CO

  • $4.84 Billion
  • Q2 2024

A detailed history of Glenview Trust CO transactions in Danaher Corp stock. As of the latest transaction made, Glenview Trust CO holds 14,864 shares of DHR stock, worth $4.13 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
14,864
Previous 15,180 2.08%
Holding current value
$4.13 Million
Previous $3.79 Million 2.03%
% of portfolio
0.08%
Previous 0.08%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$235.51 - $267.98 $74,421 - $84,681
-316 Reduced 2.08%
14,864 $3.71 Million
Q1 2024

May 14, 2024
SELL
$224.58 - $256.19 $139,688 - $159,350
-622 Reduced 3.94%
15,180 $3.79 Million
Q4 2023

Feb 12, 2024
BUY
$185.1 - $233.13 $105,136 - $132,417
568 Added 3.73%
15,802 $3.66 Million
Q3 2023

Nov 13, 2023
SELL
$233.08 - $265.59 $289,485 - $329,862
-1,242 Reduced 7.54%
15,234 $3.78 Million
Q2 2023

Aug 14, 2023
SELL
$224.99 - $256.14 $35,548 - $40,470
-158 Reduced 0.95%
16,476 $3.95 Million
Q1 2023

May 09, 2023
SELL
$239.75 - $277.0 $178,853 - $206,642
-746 Reduced 4.29%
16,634 $4.19 Million
Q4 2022

Feb 08, 2023
BUY
$241.42 - $282.29 $90,773 - $106,141
376 Added 2.21%
17,380 $4.61 Million
Q3 2022

Nov 04, 2022
SELL
$247.06 - $1507.4 $36,811 - $224,602
-149 Reduced 0.87%
17,004 $4.39 Million
Q2 2022

Aug 10, 2022
SELL
$237.11 - $299.66 $319,624 - $403,941
-1,348 Reduced 7.29%
17,153 $4.35 Million
Q1 2022

May 11, 2022
SELL
$257.27 - $315.76 $53,512 - $65,678
-208 Reduced 1.11%
18,501 $5.43 Million
Q4 2021

Feb 10, 2022
SELL
$292.08 - $329.01 $151,297 - $170,427
-518 Reduced 2.69%
18,709 $6.16 Million
Q3 2021

Nov 12, 2021
SELL
$272.21 - $332.43 $213,957 - $261,289
-786 Reduced 3.93%
19,227 $5.85 Million
Q2 2021

Aug 11, 2021
SELL
$225.08 - $271.69 $14,855 - $17,931
-66 Reduced 0.33%
20,013 $5.37 Million
Q1 2021

May 12, 2021
SELL
$212.38 - $245.9 $184,133 - $213,195
-867 Reduced 4.14%
20,079 $4.52 Million
Q4 2020

Feb 02, 2021
SELL
$212.5 - $245.46 $160,225 - $185,076
-754 Reduced 3.47%
20,946 $4.65 Million
Q3 2020

Nov 12, 2020
SELL
$177.16 - $215.33 $211,883 - $257,534
-1,196 Reduced 5.22%
21,700 $4.67 Million
Q2 2020

Aug 12, 2020
SELL
$128.7 - $176.83 $172,200 - $236,598
-1,338 Reduced 5.52%
22,896 $4.05 Million
Q1 2020

Apr 28, 2020
SELL
$121.39 - $169.05 $876,314 - $1.22 Million
-7,219 Reduced 22.95%
24,234 $3.35 Million
Q4 2019

Feb 06, 2020
SELL
$133.47 - $153.48 $130,667 - $150,256
-979 Reduced 3.02%
31,453 $4.83 Million
Q3 2019

Nov 14, 2019
SELL
$135.4 - $146.47 $182,519 - $197,441
-1,348 Reduced 3.99%
32,432 $4.68 Million
Q2 2019

Aug 08, 2019
SELL
$124.88 - $143.73 $299,087 - $344,233
-2,395 Reduced 6.62%
33,780 $0
Q1 2019

May 14, 2019
SELL
$97.62 - $132.29 $1.34 Million - $1.81 Million
-13,719 Reduced 27.5%
36,175 $4.78 Million
Q4 2018

Feb 14, 2019
SELL
$94.85 - $109.54 $218,439 - $252,270
-2,303 Reduced 4.41%
49,894 $5.15 Million
Q3 2018

Nov 14, 2018
SELL
$98.13 - $108.9 $549,037 - $609,295
-5,595 Reduced 9.68%
52,197 $5.67 Million
Q2 2018

Aug 10, 2018
SELL
$96.1 - $103.24 $619,748 - $665,794
-6,449 Reduced 10.04%
57,792 $5.7 Million
Q1 2018

May 14, 2018
SELL
$92.16 - $103.8 $693,227 - $780,783
-7,522 Reduced 10.48%
64,241 $0
Q4 2017

Feb 06, 2018
SELL
$85.26 - $94.62 $767 - $851
-9 Reduced 0.01%
71,763 $6.66 Million
Q3 2017

Nov 07, 2017
BUY
$79.29 - $88.45 $5.69 Million - $6.35 Million
71,772
71,772 $6.16 Million

Others Institutions Holding DHR

# of Institutions
2,390
Shares Held
563M
Call Options Held
3.94M
Put Options Held
4.1M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $202B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Glenview Trust CO Portfolio

Follow Glenview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email